An Anti-MRSA Phage From Raw Fish Rinse: Stability Evaluation and Production Optimization

Area of Science:

• Microbiology and Virology
• Antimicrobial Resistance Research
• Biotechnology and Pharmaceutical Development

Background:

• Increasing antibiotic resistance in pathogens like methicillin-resistant Staphylococcus aureus (MRSA) necessitates novel therapeutic strategies.
• Bacteriophages, natural predators of bacteria, are emerging as a promising alternative to conventional antibiotics.
• The need for effective anti-MRSA agents is critical due to the rise of multidrug-resistant infections.

Purpose of the Study:

• To isolate and characterize bacteriophages with potent lytic activity against MRSA.
• To identify the bacteriophage with the broadest host range and optimize its production.
• To evaluate the stability and potential pharmaceutical applications of the most effective anti-MRSA bacteriophage.

Main Methods:

• Isolation of bacteriophages from environmental sources (egg rinses, milk, raw meat rinses).
• Screening of isolated phages for lytic activity against 23 clinical MRSA isolates.
• Characterization using electron microscopy, stability tests (pH, temperature, UV, solvents), and production optimization via response surface methodology.

Main Results:

• Five phages were isolated, with one from raw fish rinse exhibiting activity against all tested MRSA isolates.
• This broad-host-range phage, likely a Siphoviridae family member, demonstrated good thermal, pH, UV, and solvent stability.
• Optimization of production conditions (pH 7, 0.5% sucrose, 0.1% peptone, 28°C, 10^7 CFU/ml inoculum) yielded a 2 log-fold increase in phage titer.

Conclusions:

• A stable, broad-spectrum bacteriophage with significant lytic activity against MRSA was successfully isolated and characterized.
• The phage's stability under various conditions suggests its potential as a viable therapeutic agent for MRSA infections.
• Bacteriophage therapy represents a promising strategy to combat multidrug-resistant pathogens like MRSA.